News

Deal Announcements

Mersana Raises $6 Million Venture Capital Debt

Monday, April 25, 2011 5:57:00 AM PDT | VentureDeal Staff
   Cambridge, Massachusetts  --  Pharmaceutical technology company Mersana (formerly known as Nanopharma Corp.) has landed $6 million in new venture capital debt.

Mersana says that it is developing new oncology agents based on "Fleximer", which is a material that enhances the safety and efficacy of drugs.

Investors in the financing were not disclosed in the SEC regulatory filing.

The company is still seeking $4 million in additional financing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1